methoxyhydroxyphenylglycol has been researched along with Panic Disorder in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 16 (80.00) | 18.2507 |
| 2000's | 4 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blanco, C; Coplan, J; Klein, DF; Liebowitz, MR; Marshall, RD; Printz, D | 1 |
| Alvarenga, M; Barton, D; Brenchley, C; Dawood, T; Esler, M; Guo, L; Haikerwal, D; Hastings, J; Jennings, G; Kalff, V; Kaye, D; Kelly, M; Lambert, E; Lambert, G; Pier, C; Richards, J; Socratous, F; Wiesner, G | 1 |
| den Boer, JA; Haigh, JR; Traub, M; van Megen, HJ; Westenberg, HG | 1 |
| Black, JE; Heninger, GR; Kosten, TR; Malison, RT; McDougle, CJ; Price, LH; Zimmermann, RC | 1 |
| Grunhaus, L; Guthrie, SK; Hariharan, M; Pande, AC | 1 |
| Charney, DS; Goddard, AW; Goodman, WK; Heninger, GR; Sholomskas, DE; Woods, SW | 1 |
| Charney, DS; Heninger, GR; Johnson, D; Krystal, JH; Morgan, CA; Nagy, LM; Nicolaou, A; Southwick, SM | 1 |
| Cooper, T; Coplan, JD; Gorman, JM; Martinez, J; Papp, L; Pine, D; Rosenblum, LA | 1 |
| de Leeuw, AS; Den Boer, JA; Slaap, BR; Westenberg, HG | 1 |
| Den Boer, JA; Kahn, RS; van Megen, HJ; Westenberg, HG | 1 |
| Den Boer, JA; Slaap, BR; van Vliet, IM; Westenberg, HG | 1 |
| Cooper, T; Coplan, JD; Gorman, JM; Klein, DF; Martinez, J; Papp, LA; Pine, D; Rosenblum, LA | 1 |
| den Boer, JA; Slaap, BR | 1 |
| Bremner, JD; Charney, DS; Hauger, RL; Morgan, CA; Rasmusson, AM; Southwick, SM | 1 |
| Hisadomi, S; Maeda, H; Tanaka, M; Toyomasu, K; Yajima, J; Yamada, S; Yamauchi, K | 1 |
| Charney, DS; Heninger, GR; Krystal, JH; Nagy, LM; Woods, SW | 1 |
| Charney, DS; Heninger, GR; Krystal, JH; McDougle, CJ; Price, LH; Woods, SW | 1 |
| Carreira, I; Casique, M; Lima, L; Morales, M; Silva, C | 1 |
| Abelson, JL; Bronzo, M; Cameron, OG; Curtis, GC; Glitz, D; Lee, MA | 1 |
| Gurguis, GN; Mefford, IN; Uhde, TW | 1 |
1 review(s) available for methoxyhydroxyphenylglycol and Panic Disorder
| Article | Year |
|---|---|
Review of current treatment in panic disorder.
Topics: Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Benzodiazepines; Humans; Methoxyhydroxyphenylglycol; Panic Disorder; Psychotropic Drugs; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1998 |
11 trial(s) available for methoxyhydroxyphenylglycol and Panic Disorder
| Article | Year |
|---|---|
Increased brain serotonin turnover in panic disorder patients in the absence of a panic attack: reduction by a selective serotonin reuptake inhibitor.
Topics: Adult; Brain; Case-Control Studies; Catheterization, Central Venous; Catheterization, Peripheral; Cerebrovascular Circulation; Citalopram; Genotype; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Panic Disorder; Research Design; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon | 2007 |
Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients.
Topics: Adult; beta-Endorphin; Cholecystokinin; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hydrocortisone; Melatonin; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Panic Disorder; Pentagastrin; Prolactin; Psychiatric Status Rating Scales; Psychometrics; Serotonin | 1994 |
Noradrenergic dysregulation during discontinuation of cocaine use in addicts.
Topics: Administration, Intranasal; Adult; Cocaine; Double-Blind Method; Female; Hospitalization; Humans; Hydrocortisone; Infusions, Intravenous; Insufflation; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Panic Disorder; Prospective Studies; Single-Blind Method; Substance Withdrawal Syndrome; Substance-Related Disorders; Yohimbine | 1994 |
Noradrenergic response to intravenous yohimbine in patients with depression and comorbidity of depression and panic.
Topics: Adult; Comorbidity; Depressive Disorder; Double-Blind Method; Female; Humans; Infusions, Intravenous; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Panic Disorder; Receptors, Adrenergic, alpha-2; Yohimbine | 1993 |
Effects of the serotonin reuptake inhibitor fluvoxamine on yohimbine-induced anxiety in panic disorder.
Topics: Adult; Anxiety; Arousal; Female; Fluvoxamine; Humans; Hydrocortisone; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Panic; Panic Disorder; Single-Blind Method; Yohimbine | 1993 |
Pentagastrin has panic-inducing properties in obsessive compulsive disorder.
Topics: Adult; Affect; Double-Blind Method; Female; Humans; Hydrocortisone; Male; Methoxyhydroxyphenylglycol; Obsessive-Compulsive Disorder; Panic Disorder; Pentagastrin; Prolactin | 1996 |
The panic-inducing properties of the cholecystokinin tetrapeptide CCK4 in patients with panic disorder.
Topics: Adult; Dose-Response Relationship, Drug; Female; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Panic Disorder; Tetragastrin | 1996 |
MHPG and heart rate as correlates of nonresponse to drug therapy in panic disorder patients. A preliminary report.
Topics: Adult; Biomarkers; Blood Pressure; Double-Blind Method; Female; Fluvoxamine; Heart Rate; Humans; Hydrocortisone; Male; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase Inhibitors; Panic Disorder; Piperidines; Selective Serotonin Reuptake Inhibitors; Treatment Failure | 1996 |
Noradrenergic neuronal dysregulation in panic disorder: the effects of intravenous yohimbine and clonidine in panic disorder patients.
Topics: Adult; Arousal; Blood Pressure; Clonidine; Double-Blind Method; Female; Growth Hormone; Humans; Hydrocortisone; Infusions, Intravenous; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Panic Disorder; Personality Inventory; Receptors, Adrenergic; Yohimbine | 1992 |
Dose-response relationship for oral idazoxan effects in healthy human subjects: comparison with oral yohimbine.
Topics: Adrenergic alpha-Antagonists; Adult; Affect; Behavior; Blood Pressure; Dioxanes; Dose-Response Relationship, Drug; Humans; Hydrocortisone; Idazoxan; Male; Methoxyhydroxyphenylglycol; Neurosecretory Systems; Panic Disorder; Pulse; Yohimbine | 1992 |
Endocrine, cardiovascular, and behavioral responses to clonidine in patients with panic disorder.
Topics: Adrenergic Fibers; Adult; Arousal; Blood Pressure; Clonidine; Female; Growth Hormone; Heart Rate; Humans; Male; Methoxyhydroxyphenylglycol; Panic Disorder; Personality Inventory; Single-Blind Method | 1992 |
8 other study(ies) available for methoxyhydroxyphenylglycol and Panic Disorder
| Article | Year |
|---|---|
A pilot study of noradrenergic and HPA axis functioning in PTSD vs. panic disorder.
Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Aged; Clonidine; Eye Movements; Female; Gas Chromatography-Mass Spectrometry; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Panic Disorder; Pilot Projects; Pituitary-Adrenal System; Stress Disorders, Post-Traumatic; Time Factors | 2002 |
Abnormal noradrenergic function in posttraumatic stress disorder.
Topics: Adult; Grief; Humans; Infusions, Intravenous; Life Change Events; Male; Memory; Methoxyhydroxyphenylglycol; Models, Neurological; Panic Disorder; Placebos; Psychiatric Status Rating Scales; Stress Disorders, Post-Traumatic; Sympathetic Nervous System; Yohimbine | 1993 |
Uncoupling of the noradrenergic-hypothalamic-pituitary-adrenal axis in panic disorder patients.
Topics: Adrenal Cortex; Adult; Clonidine; Female; Fluoxetine; Humans; Hypothalamo-Hypophyseal System; Male; Methoxyhydroxyphenylglycol; Panic Disorder | 1995 |
Clinical improvement with fluoxetine therapy and noradrenergic function in patients with panic disorder.
Topics: Adult; Clonidine; Female; Fluoxetine; Humans; Hydrocortisone; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Panic Disorder; Receptors, Adrenergic; Treatment Outcome | 1997 |
Low baseline and yohimbine-stimulated plasma neuropeptide Y (NPY) levels in combat-related PTSD.
Topics: Adrenergic alpha-Antagonists; Adult; Blood Pressure; Heart Rate; Humans; Male; Methoxyhydroxyphenylglycol; Neuropeptide Y; Panic Disorder; Psychiatric Status Rating Scales; Severity of Illness Index; Stress Disorders, Post-Traumatic; Warfare; Yohimbine | 2000 |
Saliva level of free 3-methoxy-4-hydroxyphenylglycol (MHPG) as a biological index of anxiety disorders.
Topics: Adjustment Disorders; Adult; Aged; Anxiety Disorders; Female; Gas Chromatography-Mass Spectrometry; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Panic Disorder; Reference Values; Saliva | 2000 |
[Treatment of patients with panic disorder and an elevated urinary excretion of MHPG using imipramine or clonazepam].
Topics: Adult; Anxiety Disorders; Clonazepam; Depression; Female; Humans; Imipramine; Lactates; Lactic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Panic Disorder; Paranoid Disorders; Prevalence; Psychological Tests; Schizophrenia | 1992 |
Hypothalamic-pituitary-adrenocortical activity in panic disorder: relationship to plasma catecholamine metabolites.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Adult; Agoraphobia; Catecholamines; Female; Homovanillic Acid; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Methoxyhydroxyphenylglycol; Panic Disorder; Pituitary-Adrenal System | 1991 |